Lifecore Biomedical, Inc. (LFCR) Ownership
LFCR ownership summary
as of October 17, 2026- Institutions
- 72.5% of shares outstanding
- Insiders
- 3.04% of shares outstanding
- Shares outstanding
- 37.9M
- Float
- 19.3M shares available to trade
- Short interest
- 8.02% 2.5M shares short
- Days to cover
- 6.32 short interest down 7.2% vs prior month
- Institutions 72.49%
- Insiders 3.04%
- Other investors 24.46%
LFCR top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Wynnefield Capital Inc | 12.41% | 4.7M | $30.0M | — | June 30, 2026 |
| 2 | Legion Partners Asset Management, LLC | 11.77% | 4.5M | $28.5M | — | June 30, 2026 |
| 3 | Greenhaven Road Investment Management, L.P. | 8.42% | 3.2M | $20.4M | −346,804 (−9.8%) | June 30, 2026 |
| 4 | 325 Capital LLC | 7.64% | 2.9M | $18.5M | +733,415 (+33.9%) | June 30, 2026 |
| 5 | BlackRock Inc | 5.31% | 2.0M | $12.8M | +135,788 (+7.2%) | June 30, 2026 |
| 6 | Vanguard Capital Management, LLC | 3.40% | 1.3M | $8.2M | −1,515 (−0.1%) | June 30, 2026 |
| 7 | Geode Capital Management, LLC | 2.26% | 856K | $5.5M | +40,393 (+5.0%) | June 30, 2026 |
| 8 | Morgan Stanley - Brokerage Accounts | 2.03% | 769K | $4.9M | +4,626 (+0.6%) | June 30, 2026 |
| 9 | State Street Corp | 1.76% | 668K | $4.3M | +26,025 (+4.1%) | June 30, 2026 |
| 10 | Quinn Opportunity Partners LLC | 1.20% | 453K | $2.9M | — | June 30, 2026 |
| 11 | DCF Advisers, LLC | 1.12% | 424K | $2.7M | — | June 30, 2026 |
| 12 | Wittenberg Investment Management Inc | 0.83% | 314K | $2.0M | +12,200 (+4.0%) | June 30, 2026 |
| 13 | Northern Trust Corp | 0.67% | 254K | $1.6M | +25,659 (+11.2%) | June 30, 2026 |
| 14 | Vanguard Fiduciary Trust Co | 0.63% | 240K | $1.5M | +2,859 (+1.2%) | June 30, 2026 |
| 15 | LPL Financial Corp | 0.55% | 207K | $1.3M | −490 (−0.2%) | June 30, 2026 |
| 16 | Vanguard Portfolio Management, LLC | 0.50% | 189K | $1.2M | +24,513 (+14.9%) | June 30, 2026 |
| 17 | Marshall Wace Asset Management Ltd | 0.47% | 177K | $1.1M | +119,117 (+204.1%) | June 30, 2026 |
| 18 | Tocqueville Asset Management L.P. | 0.40% | 152K | $967,846 | — | June 30, 2026 |
| 19 | Millennium Management LLC | 0.35% | 133K | $850,486 | −23,852 (−15.2%) | June 30, 2026 |
| 20 | The Goldman Sachs Group Inc | 0.33% | 125K | $797,117 | −43,436 (−25.8%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 10 holders added 1.1M shares and 5 cut 416K.
LFCR top mutual fund and ETF holders
18 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 2.17% | 822K | $5.2M | — | August 31, 2026 |
| 2 | iShares Russell 2000 ETF | 1.93% | 733K | $4.7M | −8,448 (−1.1%) | September 30, 2026 |
| 3 | Fidelity Small Cap Index | 0.80% | 303K | $1.9M | −373 (−0.1%) | July 31, 2026 |
| 4 | iShares Russell 2000 Value ETF | 0.73% | 276K | $1.8M | +418 (+0.2%) | September 30, 2026 |
| 5 | Fidelity Extended Market Index | 0.51% | 195K | $1.2M | +5,951 (+3.2%) | August 31, 2026 |
| 6 | Vanguard Russell 2000 ETF | 0.43% | 164K | $1.0M | +3,240 (+2.0%) | August 31, 2026 |
| 7 | Allspring Small Company Val | 0.35% | 132K | $845,069 | −2,704 (−2.0%) | August 31, 2026 |
| 8 | Allspring Small Company Value A | 0.31% | 118K | $755,475 | −2,608 (−2.2%) | August 31, 2026 |
| 9 | iShares Micro-Cap ETF | 0.24% | 91K | $577,613 | −624 (−0.7%) | September 30, 2026 |
| 10 | 1290 VT GAMCO Small Company Value IB | 0.21% | 78K | $497,640 | — | August 31, 2026 |
| 11 | Fidelity Total Market Index | 0.18% | 70K | $445,841 | — | August 31, 2026 |
| 12 | Schwab Small Cap Index | 0.18% | 69K | $440,839 | — | August 31, 2026 |
| 13 | Fidelity Series Total Market Index | 0.15% | 56K | $358,645 | — | August 31, 2026 |
| 14 | EA Bridgeway Ultra-Small Company Mkt ETF | 0.12% | 47K | $299,222 | — | September 30, 2026 |
| 15 | iShares Russell 2000 Small-Cap Idx Instl | 0.11% | 43K | $276,662 | — | August 31, 2026 |
| 16 | Fidelity Small Cap Value Index | 0.10% | 37K | $234,382 | — | July 31, 2026 |
| 17 | Stt Strt SPDR® Russell2000 US SmCapETF | 0.10% | 36K | $231,058 | +1,728 (+5.0%) | August 31, 2026 |
| 18 | Nuveen Small Cap Blend Idx R6 | 0.09% | 36K | $228,723 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
LFCR insider transactions
latest 8| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-28 | Aron R English | Sell | $7.12 | 150,419 | $1.1M |
| 2025-05-27 | Aron R English | Sell | $6.50 | 1,139,504 | $7.4M |
| 2025-05-23 | Aron R English | Sell | $6.75 | 96,137 | $648,925 |
| 2025-05-13 | Aron R English | Sell | $7.00 | 12,334 | $86,338 |
| 2025-05-12 | Aron R English | Sell | $7.03 | 45,698 | $321,257 |
| 2025-05-09 | Aron R English | Sell | $7.00 | 700 | $4,900 |
| 2025-05-07 | Aron R English | Sell | $7.01 | 15,847 | $111,087 |
| 2025-05-05 | Aron R English | Sell | $7.08 | 24,543 | $173,764 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
LFCR shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns LFCR
Institutional investors own 72.5% of Lifecore Biomedical's shares and insiders 3.04%. The largest holder is Wynnefield Capital Inc with 12.41% of the shares (4.7M), as of June 30, 2026. Among the top 20 institutions, 10 added shares and 5 reduced their stake in the latest filings. Short interest is 8.02% of the float, or 6.32 days of average trading volume. The share count rose 36.9% since 2014.
Related: LFCR analyst forecast, LFCR key metrics. See the LFCR stock overview for the latest quote and news.
LFCR ownership FAQ
Who owns the most Lifecore Biomedical stock?
The largest shareholders of Lifecore Biomedical are Wynnefield Capital Inc (12.41%), Legion Partners Asset Management, LLC (11.77%), Greenhaven Road Investment Management, L.P. (8.42%), 325 Capital LLC (7.64%), BlackRock Inc (5.31%).
What percentage of Lifecore Biomedical is owned by institutions?
Institutions hold 72.5% of Lifecore Biomedical's shares outstanding; insiders hold 3.04%.
Which funds own Lifecore Biomedical?
The largest fund holders of Lifecore Biomedical are Vanguard MStar Total Stk Mkt Idx Invest (2.17%), iShares Russell 2000 ETF (1.93%), Fidelity Small Cap Index (0.80%), iShares Russell 2000 Value ETF (0.73%), Fidelity Extended Market Index (0.51%).
What is Lifecore Biomedical's short interest?
2.5M shares of Lifecore Biomedical were sold short, 8.02% of the float; at the average daily volume it would take 6.32 days to cover.
Are insiders buying or selling Lifecore Biomedical?
Of the latest 8 reported insider transactions in Lifecore Biomedical (since May 5, 2025), 0 were purchases and 8 were sales.
How many shares of Lifecore Biomedical are outstanding?
Lifecore Biomedical has 37.9M shares outstanding, of which 19.3M are in the public float.